Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Anushka Bakshi

White paper: Are we prepared for the influx of CAR-Ts?

Download this white paper, in which we look at how market access and hospital processes will need to transform to accommodate the the influx of CAR-T therapies

Inizio

- PMLiVE

NHS trusts set a 90% target for electronic patient records by UK health secretary

Current estimates indicate that one in five NHS trusts still do not have electronic patient records

- PMLiVE

Janssen and Legend Biotech’s Carvykti receives FDA approval for patients with relapsed or refractory multiple myeloma

In the study, 98% of patients with relapsed or refractory multiple myeloma responded to a one-off treatment of the drug

- PMLiVE

Merck KGaA’s Glucophage approved in Europe as first oral diabetic medication for use during pregnancy

The oral drug offers comparable maternal blood sugar control to insulin, which needs to be injected

- PMLiVE

Sanofi and Regeneron announce positive phase 3 trial results for Dupixent

The trial involved patients with eosinophilic oesophagitis, an inflammatory disease that damages the oesophagus and makes eating and drinking painful

Rare Disease Day 2022

Shining a light on rare diseases with ‘Noah’s Story’

In recognition of Rare Disease Day, Bedrock share 4 minutes of a true story you won’t want to miss.

Bedrock Healthcare Communications

- PMLiVE

Accession welcomes Graham Ridgway as Non-Executive Chairman

Accession, a specialist pharma market access consulting and software company, announces the appointment of accomplished software CEO Graham Ridgway as Non-Executive Chairman.

Accession

- PMLiVE

Rare Disease Day – looking to the future with hope

On this year’s Rare Disease Day, Amanda Henkel, VP, Strategy, Nucleus X Consulting (part of Nucleus Global), reflects on recent advances in the rare disease setting.

Nucleus Global

- PMLiVE

Seagen’s Tukysa granted NICE recommendation for breast cancer patients

Approximately 400 patients are expected to benefit from the treatment in England and Wales annually

- PMLiVE

Celebrating the power of knowledge on International Thalassaemia Day 2022

This year’s ITD is on Sunday 8 May, promoting awareness about the global impact of the condition

Thrive webinar on women's health and tech panel discussion

Bridging the gender health gap: 9 key takeaways from Thrive’s webinar on tech and women’s health

Unequal health outcomes have been a reality for women throughout the world for far too long. But change is finally happening.

Thrive Agency

Rare Disease Day logo

Bedrock to raise awareness of Rare Disease Day 2022 with film ‘Noah’s Story’

Emily Wigginton, Bedrock’s Head of Client Services explains the inspiration behind the film.

Bedrock Healthcare Communications

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links